PureCycle Technologies (PCT) Q3 2024 earnings summary

Executive summary

• Achieved major production milestones at the Ironton Facility, including processing one million pounds of feedstock in a week and 200,000 pounds in a day, with quarter-over-quarter production growth exceeding 200% and all production now from PCR feedstock.

• Successfully addressed CP2 removal constraints, enabling higher production rates, improved product quality, and transition to more challenging post-consumer recycled feedstocks.

• Expanded product portfolio and compounding operations, enabling multiple product grades and broader customer applications, with strong customer feedback and active trials across fiber, film, injection molding, and automotive segments.

• Commercialization efforts advanced, with expectations for material revenue in Q4 2024 and ramping into 2025, including plans to supply Procter & Gamble and expansion into fiber and automotive markets.

• FDA expanded approval in June 2024 allows use of PureCycle's resin in all food contact applications, matching virgin polypropylene.

Financial highlights

• Raised over $105 million in net proceeds during the quarter through Ironton revenue bonds and a September capital raise, with unrestricted and restricted cash balances reaching $93.7 million at quarter-end.

• Operating cash expenses declined to $23.5 million in Q3, down from nearly $35 million in the previous quarter.

• Net loss for Q3 2024 was $90.6 million, with a year-to-date loss of $224.5 million and total operating costs for the nine months at $110.2 million.

• Interest expense rose 158% year-over-year to $41.7 million for the nine months, reflecting new debt and cessation of interest capitalization.

• Additional $118 million in revenue bonds held for future sale to support liquidity needs in 2025.

Outlook and guidance

• Confident in achieving nameplate capacity at Ironton over time, with focus shifting to matching production with commercial demand as customer orders ramp.

• Management believes current unrestricted liquidity is insufficient to fund operations and growth plans, raising substantial doubt about the ability to continue as a going concern, though plans to re-market bonds and operational enhancements are expected to alleviate this.

• Augusta project planned as a two-line operation with 260 million pounds per year capacity; construction expected to take 6–10 quarters once financing is secured.

• Material supply to Procter & Gamble for production is planned to begin in Q2 or Q3 of 2025.

• The company expects to seek further debt or equity financing for future growth and investment.